Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 1:22 AM
NCT ID:
NCT00024193
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically or cytologically confirmed primary neuroblastoma OR
* Presence of neuroblasts in bone marrow associated with an elevation of urinary catecholamines
* Metastatic disease demonstrated by at least 1 of the following:
* Medullary invasion (bone marrow involvement) as indicated by bone uptake on meta-iodobenzyl guanidine I 123 or bone lesions on bone scan
* Distant metastases to liver, pleura, lungs, or distant nodes
* No 11-22 translocation
PATIENT CHARACTERISTICS:
Age:
* 1 and over
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* See Disease Characteristics
Other:
* No contraindications to study drugs
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* No prior chemotherapy
* No other concurrent chemotherapy
Endocrine therapy
* Not specified
Radiotherapy
* Not specified
Surgery
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Study:
NCT00024193
Study Brief:
Protocol Section:
NCT00024193